Melanoma Risk Assessment & Tailored Intervention

Completed · Not applicable

Conditions studied: Melanoma, Skin Cancer

In brief

The investigators are conducting a study to provide evidence about the comparative effectiveness of mailed, tailored intervention materials on cancer prevention behavioral outcomes. The investigators will send out three (3) tailored mailings for participants who are assigned to the intervention group. Second, during the eligibility screening, the investigators will be assessing the relative yield and functioning of two risk assessment tools (BRAT and FEARS) on determining an individual's level of risk for skin cancer.

Key facts

Study ID

NCT01356771

Run by

University of Pennsylvania

People needed

323

Starts

2011-05-01

Expected to finish

2016-02-01

Last updated by the study team

2016-08-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• To be included in Phase I, a subject must meet all of the following criteria:
• Subjects are capable of giving informed consent
• Subjects are ≥ 18 years old.
• Subjects are English speaking and can read English
• To be included for analysis during Phase II, a subject must meet all of the following criteria:
• Subjects must meet all criteria listed in Phase I.
• Subjects are identified as Caucasian.
• Subjects must be at moderate or high risk for skin cancer, based on scores from the BRAT and Fears combined risk assessment.

You may not qualify if…

• Children under the age of 18 will not be included.
• For Phase II, previously diagnosed with melanoma.
• For Phase II, planning to be away for three (3) consecutive weeks or longer in June, July, or August

Where it is running

• University of Pennsylvania — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.